NM_000169.3:c.611G>A

Variant summary

Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PVS1PM2PP3PP5_Very_Strong

The NM_000169.3(GLA):​c.611G>A​(p.Trp204*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: not found (cov: 22)
Exomes 𝑓: 0.0 ( 0 hom. 0 hem. )
Failed GnomAD Quality Control

Consequence

GLA
NM_000169.3 stop_gained

Scores

3
2

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:3

Conservation

PhyloP100: 7.89

Publications

3 publications found
Variant links:
Genes affected
GLA (HGNC:4296): (galactosidase alpha) This gene encodes a homodimeric glycoprotein that hydrolyses the terminal alpha-galactosyl moieties from glycolipids and glycoproteins. This enzyme predominantly hydrolyzes ceramide trihexoside, and it can catalyze the hydrolysis of melibiose into galactose and glucose. A variety of mutations in this gene affect the synthesis, processing, and stability of this enzyme, which causes Fabry disease, a rare lysosomal storage disorder that results from a failure to catabolize alpha-D-galactosyl glycolipid moieties. [provided by RefSeq, Jul 2008]
RPL36A-HNRNPH2 (HGNC:48349): (RPL36A-HNRNPH2 readthrough) This locus represents naturally occurring read-through transcription between the neighboring ribosomal protein L36a and heterogeneous nuclear ribonucleoprotein H2 (H') genes on chromosome X. The read-through transcript produces a protein with similarity to the protein encoded by the upstream locus, ribosomal protein L36a. Alternatively spliced transcript variants have been identified. [provided by RefSeq, Jan 2011]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000169.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 19 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
PP5
Variant X-101400694-C-T is Pathogenic according to our data. Variant chrX-101400694-C-T is described in ClinVar as Pathogenic. ClinVar VariationId is 2138666.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000169.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GLA
NM_000169.3
MANE Select
c.611G>Ap.Trp204*
stop_gained
Exon 4 of 7NP_000160.1P06280
GLA
NM_001406747.1
c.734G>Ap.Trp245*
stop_gained
Exon 5 of 8NP_001393676.1A0A3B3IUC4
GLA
NM_001406748.1
c.611G>Ap.Trp204*
stop_gained
Exon 4 of 6NP_001393677.1A0A6Q8PHD1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GLA
ENST00000218516.4
TSL:1 MANE Select
c.611G>Ap.Trp204*
stop_gained
Exon 4 of 7ENSP00000218516.4P06280
RPL36A-HNRNPH2
ENST00000409170.3
TSL:4
c.300+5237C>T
intron
N/AENSP00000386655.4H7BZ11
GLA
ENST00000649178.1
c.734G>Ap.Trp245*
stop_gained
Exon 5 of 8ENSP00000498186.1A0A3B3IUC4

Frequencies

GnomAD3 genomes
Cov.:
22
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1070168
Hom.:
0
Cov.:
25
AF XY:
0.00
AC XY:
0
AN XY:
340662
African (AFR)
AF:
0.00
AC:
0
AN:
25905
American (AMR)
AF:
0.00
AC:
0
AN:
35152
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19171
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30094
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53320
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40486
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4069
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
816778
Other (OTH)
AF:
0.00
AC:
0
AN:
45193
GnomAD4 genome
Cov.:
22

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
2
-
-
Fabry disease (2)
1
-
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.54
D
BayesDel_noAF
Pathogenic
0.54
CADD
Pathogenic
44
DANN
Uncertain
1.0
FATHMM_MKL
Uncertain
0.97
D
PhyloP100
7.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=0/200
disease causing (fs/PTC)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.55
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.48
Position offset: 7
DS_DL_spliceai
0.55
Position offset: -28

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs869312346;
hg19: chrX-100655682;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.